Keep your Aadhaar ready to buy two Coronavirus medicines. Here’s why
New Delhi: Amid the ongoing coronavirus crisis, black marketing of masks, sanitisers, coronavirus drugs has increased and people have complained about the same. Maharashtra Home minister Anil Deshmukh recently held a meeting with FDA officials and Mumbai Police officials regarding the shortage of Remdesivir and Tocilizumab drugs in the state during the Corona Pandemic.
The Home Minister said that strict actions will be taken against black marketers. Also, FDA minister of Maharashtra Rajendra Shingne recently conducted surprise checks in Mumbai after receiving complaints about the shortage and black marketing of Ramdesivir and Tocilizumab. Now, people will need Aadhaar card and several other documents to buy these to drugs in Maharashtra.
As per a ToI report, the Maharashtra Food and Drug Administration issued a circular on Friday which made it mandatory for the kin of patients to produce Aadhaar card details, doctors’ prescription, consent form, a COVID positive report and contact details for the purchase of the anti-viral drug Remdesivir and anti-inflammatory medicine Tocilizumab.
It may be noted that the regulatory authority is already investigating if hospitals are hoarding the drugs after procuring these directly from the manufacturers. FDA minister Rajendra Shingne said the decision was taken in the wake of complaints of a shortage and concerns about the experimental drugs being sold in black.
The minister was quoted in the report saying, “We have received information that people who do not need the drug are trying to purchase it and then selling it at an inflated rate. These documents will now have to be produced by people buying it from druggists. This will help us track the sale and use of these drugs.”
It is worth mentioning that the minister made surprise checks at Masina Hospital in Byculla and a store of a wholesale druggist, SK Distributor, in Ghatkopar. FDA officials who accompanied the minister stated that hey did not find any discrepancy in the purchase and sale records. Anil Deshmukh and Shingne also had a meeting to discuss the strategy to curb black marketing and of Remdesivir and other drugs needed to treat COVID-19 patients.
“Since these drugs may have shown encouraging results on critical Covid-19 patients, their demand has gone up in the last few weeks,” Shingne said. “We have asked the licensed companies to expedite production.” An FDA official told the publication.
It is worth mentioning that the Delhi government’s Drug Control Department on Friday also stated that COVID-19 drug namely Remdesivir, Tocilizumab, Favipiravir should only be used for emergency purpose and directed the state drug controller to keep a strict vigil on the sale of these medicines to prevent black marketing.
The advisory read, “CDSCO. Govt of India has granted permission to manufacture and market the COVID-19 drug, Remdesivir to restricted emergency use only and has granted permission to only three companies for restricted emergency use subject to various conditions and restrictions.”